127 related articles for article (PubMed ID: 38608783)
1. Brain histamine improves colonic hyperpermeability through the basal forebrain cholinergic neurons, adenosine A2B receptors and vagus nerve in rats.
Ishioh M; Nozu T; Miyagishi S; Igarashi S; Funayama T; Ueno N; Okumura T
Biochem Pharmacol; 2024 Jun; 224():116201. PubMed ID: 38608783
[TBL] [Abstract][Full Text] [Related]
2. Activation of basal forebrain cholinergic neurons improves colonic hyperpermeability through the vagus nerve and adenosine A2B receptors in rats.
Ishioh M; Nozu T; Miyagishi S; Igarashi S; Funayama T; Ohhira M; Okumura T
Biochem Pharmacol; 2022 Dec; 206():115331. PubMed ID: 36330948
[TBL] [Abstract][Full Text] [Related]
3. Activation of central adenosine A2B receptors mediate brain ghrelin-induced improvement of intestinal barrier function through the vagus nerve in rats.
Ishioh M; Nozu T; Igarashi S; Tanabe H; Kumei S; Ohhira M; Takakusaki K; Okumura T
Exp Neurol; 2021 Jul; 341():113708. PubMed ID: 33771554
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin acts in the brain to block colonic hyperpermeability in response to lipopolysaccharide through the vagus nerve.
Ishioh M; Nozu T; Igarashi S; Tanabe H; Kumei S; Ohhira M; Okumura T
Neuropharmacology; 2020 Aug; 173():108116. PubMed ID: 32442542
[TBL] [Abstract][Full Text] [Related]
5. Centrally administered GLP-1 analogue improves intestinal barrier function through the brain orexin and the vagal pathway in rats.
Funayama T; Nozu T; Ishioh M; Igarashi S; Sumi C; Saito T; Toki Y; Hatayama M; Yamamoto M; Shindo M; Tanabe H; Okumura T
Brain Res; 2023 Jun; 1809():148371. PubMed ID: 37076092
[TBL] [Abstract][Full Text] [Related]
6. Brain orexin improves intestinal barrier function via the vagal cholinergic pathway.
Okumura T; Nozu T; Ishioh M; Igarashi S; Kumei S; Ohhira M
Neurosci Lett; 2020 Jan; 714():134592. PubMed ID: 31678432
[TBL] [Abstract][Full Text] [Related]
7. Oxytocin acts centrally in the brain to improve leaky gut through the vagus nerve and a cannabinoid signaling in rats.
Okumura T; Nozu T; Ishioh M; Igarashi S; Funayama T; Kumei S; Ohhira M
Physiol Behav; 2022 Oct; 254():113914. PubMed ID: 35839845
[TBL] [Abstract][Full Text] [Related]
8. Centrally administered butyrate improves gut barrier function, visceral sensation and septic lethality in rats.
Okumura T; Nozu T; Ishioh M; Igarashi S; Kumei S; Ohhira M
J Pharmacol Sci; 2021 Aug; 146(4):183-191. PubMed ID: 34116731
[TBL] [Abstract][Full Text] [Related]
9. Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models.
Nozu T; Arie H; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Int Immunopharmacol; 2024 May; 133():112099. PubMed ID: 38643709
[TBL] [Abstract][Full Text] [Related]
10. Centrally administered orexin prevents lipopolysaccharide and colchicine induced lethality via the vagal cholinergic pathway in a sepsis model in rats.
Igarashi S; Nozu T; Ishioh M; Kumei S; Saito T; Toki Y; Hatayama M; Yamamoto M; Shindo M; Tanabe H; Okumura T
Biochem Pharmacol; 2020 Dec; 182():114262. PubMed ID: 33035510
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin prevents lethality in a rat endotoxemic model through central effects on the vagal pathway and adenosine A2B signaling : Brain ghrelin and anti-septic action.
Igarashi S; Nozu T; Ishioh M; Funayama T; Sumi C; Saito T; Toki Y; Hatayama M; Yamamoto M; Shindo M; Tanabe H; Okumura T
J Physiol Biochem; 2023 Aug; 79(3):625-634. PubMed ID: 37099079
[TBL] [Abstract][Full Text] [Related]
12. Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Biomed Pharmacother; 2021 Jul; 139():111649. PubMed ID: 33957565
[TBL] [Abstract][Full Text] [Related]
13. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
Eur J Pharmacol; 2019 Jun; 852():198-206. PubMed ID: 30935894
[TBL] [Abstract][Full Text] [Related]
14. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
[TBL] [Abstract][Full Text] [Related]
15. Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
Neurogastroenterol Motil; 2020 Jun; 32(6):e13819. PubMed ID: 32056324
[TBL] [Abstract][Full Text] [Related]
16. Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
Sci Rep; 2019 Dec; 9(1):19603. PubMed ID: 31862976
[TBL] [Abstract][Full Text] [Related]
17. Peripheral apelin mediates visceral hypersensitivity and impaired gut barrier in a rat irritable bowel syndrome model.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Neuropeptides; 2022 Aug; 94():102248. PubMed ID: 35526468
[TBL] [Abstract][Full Text] [Related]
18. GHSR-1 agonist sensitizes rat colonic intrinsic and extrinsic neurons to exendin-4: A role in the manifestation of postprandial gastrointestinal symptoms in irritable bowel syndrome?
Buckley MM; O'Brien R; Buckley JM; O'Malley D
Neurogastroenterol Motil; 2019 Oct; 31(10):e13684. PubMed ID: 31311066
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats.
Nozu T; Miyagishi S; Kumei S; Nozu R; Takakusaki K; Okumura T
J Gastroenterol Hepatol; 2019 Jan; 34(1):186-193. PubMed ID: 29966173
[TBL] [Abstract][Full Text] [Related]
20. MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1.
Hou Q; Huang Y; Zhu S; Li P; Chen X; Hou Z; Liu F
Cell Physiol Biochem; 2017; 44(6):2256-2268. PubMed ID: 29258088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
